Pacira BioSciences, Inc. (NASDAQ:PCRX) Receives Average Rating of “Hold” from Brokerages
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has earned a consensus recommendation of “Hold” from the nine ratings firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and four have issued a buy recommendation on the company. […]
